Mochi Health vs Calibrate Weight Loss: Obesity Medicine Specialist vs Insurance Navigation
An independent, side-by-side comparison of Mochi Health and Calibrate for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Calibrate
Starting at $25/mo vs $149/mo
Most Medications
Mochi Health
2 medications vs 2
Best for Beginners
Mochi Health
Hybrid, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Mochi Health | Calibrate | Savings |
|---|---|---|---|
| Semaglutide | $149/monthly | $25/monthly | Save $124/mo with Calibrate |
| Tirzepatide | Not offered | $299/monthly | Only at Calibrate |
Pros and Cons
Mochi Health
- Video consultations with board-certified obesity medicine providers
- Registered dietitian access included in membership
- Orforglipron (oral GLP-1) available at $149/mo
- Brand-name injectable GLP-1s available through insurance, plus non-GLP-1 alternatives
- Insurance support with prior authorization handling
- Available in 49 states
- Membership fee is required on top of medication cost
- Lab work not included (recommended but at additional cost)
- Some patients have reported shipping delays
- Early-stage company with limited funding (~$1M raised) compared to established players
- Compounded GLP-1 options permanently unavailable
- Not available in Alabama
Calibrate
- Comprehensive metabolic health program (not just medication)
- Lab testing and metabolic panels included
- Video consultations with obesity medicine specialists
- Works with insurance to cover GLP-1 medication costs
- Focus on sustainable weight loss and metabolic reset
- Higher program cost ($299/mo for coaching + medication separate)
- One-year commitment required
- Insurance coverage for medication not guaranteed
- Not available in all states
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 15, 2026
Mochi Health vs Calibrate Weight Loss (2026)
Mochi Health and Calibrate both sit above the entry-level cash-pay GLP-1 telehealth tier — they are more clinically substantive than Henry Meds or Hims. But they differentiate on where they add the most value: Mochi on specialist clinical depth, Calibrate on insurance navigation. Patients need to identify which problem they're trying to solve.
Quick Comparison
| Mochi Health | Calibrate | |
|---|---|---|
| Monthly cost | ~$149–299/month | ~$99/month + copays |
| Program length | Ongoing / subscription | 1-year structured program |
| Prescribers | Board-certified obesity medicine physicians | Physicians (mixed specialties) |
| Insurance navigation | Yes — insurance team | Yes — core specialty |
| Compounded GLP-1 | Yes (cash-pay) | Available (if insurance fails) |
| Dietitian access | Yes — registered dietitian | Yes — registered dietitian |
| Coaching | Obesity medicine + dietitian coaching | Health coaches + dietitian |
| Lab testing | Comprehensive — included | Included in program |
| Body composition tracking | Emphasized (smart scale options) | Weight tracking; less body comp focus |
| Medication options | GLP-1 + non-GLP-1 options | Primarily GLP-1 focused |
Mochi Health: The Obesity Medicine Specialist Platform
Mochi's primary differentiator is prescriber credential: board-certified obesity medicine physicians. This is meaningful — obesity medicine board certification (ABOM) requires dedicated training in the biology of obesity, pharmacotherapy, behavior change, and metabolic science. Most telehealth GLP-1 providers use general practitioners or nurse practitioners; Mochi uses specialists.
What obesity medicine certification adds:
- Expertise in complex obesity management (failed prior attempts, atypical presentations)
- Comfort with combination pharmacotherapy (GLP-1 + other agents)
- Understanding of body composition goals beyond scale weight
- Ability to manage complex comorbidities (T2D, PCOS, MASH, sleep apnea) in context
Mochi insurance: Mochi has an insurance navigation team. It is not their primary differentiator, but it exists — they can work to get medications covered for eligible patients.
Mochi pricing: Higher than most GLP-1 telehealth (~$149–299/month depending on plan) — reflecting the specialist-level care model.
Calibrate: The Insurance Navigation Specialist
Calibrate's differentiator is getting GLP-1 medications covered by insurance — the team actively navigates prior authorization, appeals denials, and interfaces with employer benefits. For patients with commercial insurance, this can unlock brand-name Wegovy or Zepbound at copay pricing vs $900+/month cash-pay.
What insurance navigation adds:
- Prior authorization submission and tracking
- Clinical documentation support for appeals
- Knowledge of which insurers cover GLP-1 under which criteria
- Employer benefit navigation (some large employers cover GLP-1; Calibrate knows how to access this)
Calibrate clinical depth: The program includes physician video visits, registered dietitian access, quarterly milestones, and a year-long structured curriculum. This is more clinical depth than cash-pay-only platforms, but less specialist depth than Mochi.
Calibrate pricing: ~$99/month program fee + insurance copays. If insurance is obtained, total cost can be significantly lower than Mochi.
Clinical Outcomes
Both programs with active GLP-1 medication produce similar weight loss outcomes (~15–20%) because the medication is the primary driver. Differentiation in outcomes relates to:
- Specialist management (Mochi): May catch reasons for suboptimal response (inadequate dose, wrong medication class, insulin resistance requiring metformin co-prescribing)
- Insurance access (Calibrate): Determines whether patients can sustain medication long-term (financial barrier is a leading cause of discontinuation)
The Insurance Scenario Comparison
| Patient Scenario | Better Choice | Reason |
|---|---|---|
| Complex obesity, multiple failed programs, needs specialist evaluation | Mochi | Board-certified obesity medicine |
| Commercial insurance with possible GLP-1 coverage | Calibrate | Insurance navigation is core capability |
| Already know which medication you need, want specialist oversight | Mochi | Clinical depth |
| Employer benefit GLP-1 program available | Calibrate | Maximizes insurance navigation value |
| No insurance, paying cash | Mochi (if willing to pay for specialist) or lower-cost option | Insurance nav has less value without insurance |
| Complex comorbidities (T2D + PCOS + MASH) | Mochi | Specialist can manage multi-system complexity |
Pricing Over 24 Months
| Scenario | Mochi (24 mo) | Calibrate (24 mo) |
|---|---|---|
| GLP-1 cash-pay compounded + program | ~$3,600–7,200 + ~$3,600 med = $7,200–10,800 | ~$2,376 + ~$3,600 med = $5,976 |
| GLP-1 covered by insurance ($40 copay) | ~$3,600 + ~$960 copay = $4,560 | ~$2,376 + ~$960 copay = $3,336 |
Calibrate's lower program fee saves meaningful money over 2 years — but only if the insurance navigation actually works. If coverage is denied, the value of Calibrate's specialty is reduced.
Who Each Program Serves Best
Mochi Health is better if you:
- Have a complex metabolic history and want specialist-level evaluation
- Want combination medication options if GLP-1 alone is insufficient
- Have tried other programs without adequate results
- Are willing to pay more for specialist board-certified obesity medicine
- Want emphasis on body composition, not just scale weight
Calibrate is better if you:
- Have commercial insurance and believe GLP-1 coverage is possible
- Want the structured year-long program with quarterly clinical milestones
- Prioritize the registered dietitian and coaching curriculum
- Want lower ongoing cost if insurance navigation succeeds
- Don't need specialist-level obesity medicine evaluation
Related Resources
- Mochi Health Review — full program review
- Calibrate Weight Loss Review — full review
- Mochi Health vs Ro — Mochi vs cash-pay alternative
- GLP-1 Insurance Denial FAQ — navigating insurance denials
- Best GLP-1 Programs with Insurance Navigation — full ranking
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of March 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in March 2026. Here's what patients need to know and what to do.
Read guide →